author-photo

Nirjhar Mundkur

19

Papers

2

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Cellworks Omics Biology Model (CBM) to predict therapy response and identify novel biomarkers for 5FU-based combination therapy in gastric cancer patients.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Cellworks Omics Biology Model (CBM) to predict therapy response and identify biomarkers for all-trans retinoic acid (ATRA) benefit as addition to induction chemotherapy in adults with acute myeloid leukemia (AML).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Superior overall survival (OS), progression-free survival (PFS), and clinical response (CR) predictions for patients with non-small cell lung cancer (NSCLC) using Cellworks Singula: myCare-022-05.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Therapy Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Is Predictive of Individual Acute Myeloid Leukemia (AML) Patient Probability of Clinical Response (CR) and Overall Survival (OS): Mycare-023

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Combination chemotherapy versus temozolomide (TMZ) for patients with MGMT methylated (m-MGMT) glioblastoma (GBM): Results of cellworks omics biosimulation—MyCare-015.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prediction of Clinical Response for Frontline Treatment of Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-02

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of Cellworks Omics Biosimulation Therapy Response Predictions for Patients with Acute Myeloid Leukemia (AML) Using Cellworks Singula™: Mycare-020-01

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Monosomy 7 and Co-Occurrent Genomic Aberrations Determine Chemotherapy Response in Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-04

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: Mycare-020-02

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)